Home health giant Amedisys Inc. (NASDAQ: AMED) has agreed to a $150 million settlement with the federal government for allegations that the company submitted false home healthcare billings to Medicare. The national provider of home health care services allegedly improperly billed Medicare for ineligible patients and services including billing for services that were not medically […]
Amedisys Inc.
National home care provider Amedisys, Inc. (Nasdaq: AMED) says it will close and consolidate a total of 54 locations across the country. The locations consist of 23 home health and six hospice branches that will close, while consolidating 25 other home health and hospice care centers nationwide. As a result of these actions, Amedisys expects […]
Nationwide home care and hospice provider Amedisys (NASDAQ: AMED) said the company is focused on transformation following the announcement of missed earnings Wednesday and a net loss from continuing operations in the fourth quarter of 2013. The company cited increasing health care costs for employees as an unforeseen drag on company performance as well as […]
Home health intervention with medication management can reduce hospital readmissions by as much as 8%, according to a joint study from national home health care provider Amedisys and Purdue University. The study, conducted from January 2012 through April 2012, reveals that a patient population utilizing medication intervention post-discharge had a 4% hospital admission rate, compared […]
Partnering with home health care agencies is emerging as a new model of care and a core strategy in preventing hospital readmissions, according to a new survey. Home health partnerships were the number-one strategy that 73% of senior hospital leaders adopt to lower preventable readmissions, as noted in a survey conducted by HealthLeaders Media Intelligence […]
Home health care and hospice provider Amedisys (NASDAQ: AMED) today announced adjusted earnings from continuing operations down 38% in the second quarter to $5.4 million or $0.17 per diluted share. The adjusted results reflect the addition of exit activity costs, the gain on sale of care centers and legal fees associated with investigations, the company […]
Publicly held home health companies faltered on Wall Street in response to an announcement last week from the Centers for Medicare and Medicaid Services proposing Medicare reimbursements to home health providers will fall 1.5% in 2014, or $290 million based on estimates. Public companies including Gentiva Health Services (NASDAQ: GTIV) and Amedisys Inc. (NASDAQ: AMED) […]
Amedisys Inc. (NASDAQ: AMED) announced Friday it has retained a mergers and acquisitions company to help divest dozens of care centers in the coming months. A nationwide health care at home company that currently covers 380,000 patients, Amedisys announced in its first quarter earnings statement it was planning to divest 50 of its care properties, […]
Home health and hospice company Amedisys, Inc. (NASDAQ:AMED) reported a net income of $7.2 million for the fourth quarter ended Dec. 31, 2012 on an adjusted basis, a 50.5% decrease from the previous year’s fourth quarter proceeds of $14.5 million. For all of 2012, earnings attributable to Amedisys were down nearly 51% to $32.8 million. […]
An article posted last week by the Wall Street Journal reported that the steps to reducing hospital readmission rates is “without an easy fix.” Detailing recent studies linking readmission rates to poor post-care coordination, the article caught the attention of Amedisys’ Chief Medical Officer Michael Fleming, MD, FAAFP. Because the nation’s healthcare needs are changing, Fleming […]
Subscribe
Receive industry updates and breaking news from HHCN